We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+8.14%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3B
AUM Growth
-$140M
Cap. Flow
-$317M
Cap. Flow %
-10.57%
Top 10 Hldgs %
28.72%
Holding
6,693
New
497
Increased
2,742
Reduced
2,422
Closed
658

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$73.5M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$65.4M
3
MSFT icon
Microsoft
MSFT
+$34M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$12.5M
5
CMCSA icon
Comcast
CMCSA
+$11.4M

Sector Composition

Rank Sector Weight
1 Technology 18.86%
2 Financials 7.81%
3 Consumer Discretionary 7.79%
4 Industrials 7.37%
5 Healthcare 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CWBC
4051
DELISTED
Community West BanCshares
CWBC
$10.9K ﹤0.01%
895
-508
-36% -$6K
VBNK
4052
VersaBank
VBNK
$646M
$10.9K ﹤0.01%
1,439
-279
-16% -$2.02K
VVX icon
4053
V2X
VVX
$2.53B
$10.9K ﹤0.01%
219
-105
-32% -$4.58K
IMNN icon
4054
Imunon
IMNN
$6.64M
$10.8K ﹤0.01%
645
+9
+1% +$149
SNES icon
4055
SenesTech
SNES
$6.94M
$10.8K ﹤0.01%
+81
New +$12.8K
SANW
4056
DELISTED
S&W Seed Co
SANW
$10.8K ﹤0.01%
467
+140
+43% +$3.34K
FGI icon
4057
FGI Industries
FGI
$24.4M
$10.8K ﹤0.01%
1,252
+269
+27% +$2.42K
INDP icon
4058
Indaptus Therapeutics
INDP
$143M
$10.8K ﹤0.01%
202
-17
-8% -$992
GETR
4059
DELISTED
Getaround, Inc.
GETR
$10.8K ﹤0.01%
30,885
+29,453
+2,057% +$12.8K
TILE icon
4060
Interface
TILE
$2.25B
$10.8K ﹤0.01%
1,229
-574
-32% -$4.4K
CCO icon
4061
Clear Channel Outdoor Holdings
CCO
$1.19B
$10.8K ﹤0.01%
7,883
-8,114
-51% -$10.1K
EVLO
4062
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$10.8K ﹤0.01%
3,318
+1,702
+105% +$5.06K
HAFC icon
4063
Hanmi Financial
HAFC
$959M
$10.8K ﹤0.01%
722
-4,834
-87% -$77.1K
BBGI icon
4064
Beasley Broadcasting Group
BBGI
$45M
$10.8K ﹤0.01%
528
+77
+17% +$1.48K
JMIA
4065
Jumia Technologies
JMIA
$775M
$10.8K ﹤0.01%
3,151
+2,231
+243% +$6.84K
CTXR icon
4066
Citius Pharmaceuticals
CTXR
$20.5M
$10.8K ﹤0.01%
+359
New +$11.8K
BTCS icon
4067
BTCS Inc
BTCS
$54.8M
$10.8K ﹤0.01%
9,084
+3,186
+54% +$4.02K
DIT icon
4068
AMCON Distributing
DIT
$68.3M
$10.8K ﹤0.01%
80
-85
-52% -$10.9K
SOPH icon
4069
SOPHiA GENETICS
SOPH
$644M
$10.8K ﹤0.01%
2,400
+1,826
+318% +$8.25K
UONEK icon
4070
Urban One Class D
UONEK
$23.7M
$10.8K ﹤0.01%
179
-36
-17% -$2.04K
BAK icon
4071
Braskem
BAK
$837M
$10.7K ﹤0.01%
922
+869
+1,640% +$8.23K
UPH
4072
DELISTED
UpHealth, Inc.
UPH
$10.7K ﹤0.01%
5,713
+1,143
+25% +$1.89K
VMD icon
4073
Viemed Healthcare
VMD
$354M
$10.7K ﹤0.01%
1,098
-710
-39% -$7.21K
ASTC icon
4074
Astrotech Corp
ASTC
$18M
$10.7K ﹤0.01%
758
-375
-33% -$4.2K
MTW icon
4075
Manitowoc
MTW
$741M
$10.7K ﹤0.01%
570
-298
-34% -$4.81K

Similar funds

Tower Research Capital (TRC)'s Q2 2023 Portfolio in Review

As of Q2 2023, Tower Research Capital (TRC) held 6,693 positions worth $3B, down 4.5% from $3.14B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) withdrew a net $317M in Q2 2023, closing 658 positions and reducing 2,422 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $22.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares MSCI USA Min Vol Factor ETF worth $5.5M.

  • Tower Research Capital (TRC)'s largest Q2 2023 buy was iShares MSCI USA Min Vol Factor ETF: 74,022 shares worth $5.5M.
  • Tower Research Capital (TRC) added most to Apple in Q2 2023, an estimated $73.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2023 reduction was TSMC, cutting an estimated $335M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q2 2023, selling an estimated $22.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $3B portfolio in Q2 2023.
  • Tower Research Capital (TRC) opened 497 new positions and closed 658 in Q2 2023.
  • Tower Research Capital (TRC)'s portfolio value fell 4.5% quarter-over-quarter to $3B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2023, filed 14 Aug 2023.